UK Government Unlocks Game-Changing Drug Pricing Strategy
UK braces as drug pricing shifts dramatically in market access landscape.
UK braces as drug pricing shifts dramatically in market access landscape.
Regeneron boosts its pipeline with multispecific platform for disease innovation.
Thermo Fisher acquisition hits billion mark for Clario.
HAS strengthens stroke management for faster, equitable emergency care access.
Sweden expands reimbursement decisions driving biotech access and patient impact.
NICE issues breakthrough HTA decision on Bayer’s prostate cancer therapy.
NICE drives innovation, reshaping MASH evaluations with transformative guidance.
The billion-dollar acquisition advances Avidity’s RNA platform with momentum.
Biogen strengthens Immunology pipeline through $1B Vanqua acquisition deal.
Poland’s Ministry of Health has announced its largest-ever reimbursement list update